Navigation Links
TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Date:5/17/2013

BOSTON, May 17, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease (CKD) market. This particular landscape highlights over 90 international companies with drugs and devices currently on the market and in development addressing CKD and its sequelae.

(Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO )

Topics include:

  • hypertension - renal denervation
  • diabetic nephropathy - antifibrotics
  • glomerular nephritis – biologics targeting immune complexes
  • polycystic kidney disease – small molecule inhibitors
  • anemia – hepcidin inhibitors
  • hyperkalemia – safer agents
  • mineral and bone disease – cost saving strategies

TechAtlas' analysts have evaluated each technology according to the parameters that dictate their commercial competitiveness, including benefit/risk, cost, convenience, and reimbursement dynamics (e.g., exposure to bundling). For example, non-calcium-based phosphate binders will compete on price as oral drugs enter the dialysis bundle, but certain iron-based agents will have an advantage since they also reduce the need for expensive anemia drugs.  Among future anemia agents, injectable antibodies and RNAi targeting hepcidin will have different times to onset of action, and both will compete against the more convenient oral HIF-PH inhibitors. However, all of these anemia therapies will face pricing pressure in a bundled dialysis environment and will be better received for treating anemia in pre-dialysis patients but only in certain geographies.

The TechAtlas map graphically presents every CKD-related technology, old and new, in its proper context to clearly show the relationship of competing and complementary products for specific unmet needs.  This map was built on extensive primary research, including interviews with companies, investors, key opinion leaders in the nephrology community, academic researchers, technical experts, consumers of technologies, and other stakeholders in the field, as well as an exhaustive review of public and proprietary resources.

TechAtlas Group's current subscribers have reported that their researchers, BD analysts, and executives have used it to guide their business development efforts, R&D resource allocation, and competitive intelligence.

Some of the 90+ companies featured on the TechAtlas Chronic Kidney Disease landscape include: AbbVie, Amgen, Astellas, FibroGen, Fresenius, Johnson & Johnson, Keryx, and ZS Pharma.

For further information on obtaining a copy of this report through an annual subscription, please consult our website:

http://www.techatlasgroup.com/order.html

About TechAtlas Group

TechAtlas Group, LLC brings a novel, multi-dimensional, visually stimulating approach to decision makers who are already flooded with data and information but are seeking context and actionable insight to guide their resource allocation for R&D and commercial activities. Founded in 2011, TechAtlas Group, LLC is headquartered in Boston, MA.  Their large team of PhDs is trained to analyze the viability and commercial competitiveness of a variety of technologies and distill their insights into a visual landscape.  As each field evolves, the maps are updated and issued to subscribers.  Their mission is to convey in one dynamic diagram what has conventionally been crammed into a static 100-page report.


'/>"/>
SOURCE TechAtlas Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hemp, Inc. Signs Letter of Intent with One of Chinas Largest Agricultural Producers, Yasheng Group
2. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
3. Apexus Answers Offers New Service: Live Scheduled 340B Group Chat
4. The MED Group Announces New Agreement with CareCentrix Effective May 1, 2013
5. ASSA ABLOY Door Group Announces RF Shielding Openings
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
7. Behavioral Health Group (BHG) Outpatient Opioid Treatment Centers Offer New Medication Option for Patients
8. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
9. Dr. William McGuire, Former UnitedHealth Group CEO, Joins Rebiotix Inc. Board of Directors
10. Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China
11. Industry Group To Vow That Boston Terror Attack Victims "Will Walk And Run Again"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/1/2017)... 1, 2017 Michael Penna , President ... highlights opportunities for growth in his response to the ... Equity is seeking a buyer for eMDs. Penna,s company, ... healthcare solutions Value Added Reseller and national leader in ... "As the healthcare market continues to dictate ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... ... PITTSBURGH...An inventor, from Richmond Hill, Ga., thought there needed to be a quick ... invented the COMPLETE PATIENT CHART. , The COMPLETE PATIENT CHART provides a more effective ... alternative to paper charts and clipboards. As a result, it increases efficiency and it ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... science and technology-enabled services supporting clinical research, today announces that 30 of ... aspects of the drug development lifecycle at upcoming industry conferences and webinars. ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to include ... the hottest Korean cosmetics and fashion trends sweeping the nation. The decision to expand ... for the great offerings that allow Koreans everywhere to look their best every single ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Majestic Unicorn”: a poignant ... “The Majestic Unicorn” is the creation of published author, Dayna Chantel, an artist and ... far and wide to march aboard the cypress ark-vessel. Male and female, no matter ...
(Date:9/25/2017)... ... ... kill Ash trees in as little as 1-3 years. The signs of this ... Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in Northeast Philadelphia ... decline from Emerald Ash Borers, two Ash trees continue to thrive. , "The ...
Breaking Medicine News(10 mins):